Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | JAK2 | O60674 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27758659 | 0.87 | ALOX15 (0.48) | CA1CA2TP53TSHRGAA | |
| SCHEMBL28575814 | 0.87 | ALOX15 (0.48) | CA1CA2TP53TSHRGAA | |
| SCHEMBL10713156 | 0.86 | CA1 (0.48) | CA1CA2TP53TSHRGAA | |
| SCHEMBL689262 | 0.84 | GAA (0.47) | CA1CA2TP53TSHRGAA | |
| SCHEMBL8399530 | 0.83 | CA1 (0.45) | CA1CA2TP53TSHRGAA | |
| SCHEMBL27978203 | 0.82 | CA1 (0.46) | CA1CA2TP53TSHRGAA | |
| SCHEMBL1826831 | 0.81 | TDP1 (0.47) | KMT2AALDH1A1KDM4EHPGDTDP1 | |
| SCHEMBL3361719 | 0.81 | KMT2A (0.53) | CA1CA2MAPTLMNAKMT2A | |
| SCHEMBL6371250 | 0.80 | GABRA1 (0.47) | CA1CA2TP53TSHRGAA | |
| SCHEMBL10787248 | 0.80 | GAA (0.44) | CA1CA2TP53TSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069268-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems, Inc. (US) | 2021-03-11 | — | — | US | claimed |
| CN-111587376-A | Metabonomics modification of mammalian infants | 进化生物系统股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| EP-3681521-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems Inc. (US) | 2020-07-22 | — | — | EP | claimed |
| WO-2019055718-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems, Inc. (US) | 2019-03-21 | — | — | WO | claimed |
| US-5834510-A | TOPICAL APPLICATION | TRISTRATA TECHNOLOGY, INC. | 1998-11-10 | — | — | US | claimed |
| CN-117342953-A | Use of rosmarinic acid and analogues thereof in the treatment of vascular diseases | 西北大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-117304022-A | Method for synthesizing rosmarinic acid and analogues thereof | 西北大学 | 2023-12-29 | — | — | CN | disclosed |
| CN-114746745-A | Detection of analytes by protein switches | 美国雅培糖尿病护理公司 | 2022-07-12 | — | — | CN | disclosed |
| US-20210069268-A1 | METABOLOMIC REVISION OF MAMMALIAN INFANTS | Evolve Biosystems, Inc. (US) | 2021-03-11 | — | — | US | disclosed |
| CN-111989042-A | Lactate sensor and related methods | 雅培糖尿病护理股份有限公司 | 2020-11-24 | — | — | CN | disclosed |
| US-10842728-B2 | Light-absorbing compositions and methods of use | ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| CN-111587376-A | Metabonomics modification of mammalian infants | 进化生物系统股份有限公司 | 2020-08-25 | — | — | CN | disclosed |
| EP-1012164-A1 | SERINE PROTEASE INHIBITORS | Akzo Nobel N.V. (NL) | 2000-06-28 | — | — | EP | disclosed |
| WO-1997031939-A1 | SERINE PROTEASE INHIBITORS | AKZO NOBEL N.V. (NL) | 1997-09-04 | — | — | WO | disclosed |
| CN-1028098-C | Preparation of amino ketone compound | MONSANTO CO (US) | 1995-04-05 | — | — | CN | disclosed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | disclosed |
| CN-1049338-A | The preparation method of amino ketone compound | PHARMACEUTICALS INST CHINESE A (CN) | 1991-02-20 | — | — | CN | disclosed |
| EP-0052927-B1 | STRETCHED FILM STRUCTURE OF THE POLY-1,3-PHENYLENE TEREPHTHALATE TYPE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1987-01-07 | — | — | EP | disclosed |
| US-4390683-A | Stretched film structure of the poly-1,3-phenylene terephthalate type | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-06-28 | — | — | US | disclosed |
| EP-0052927-A2 | Stretched film structure of the poly-1,3-phenylene terephthalate type | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10842728-B2 | Light-absorbing compositions and methods of use | CYBA, BROX, S100A6 | CA1 2077/4885CA2 2873/4885TP53 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.